Avoid These 2 Tech Stocks that Wall Street Hates

: UPST | Upstart Holdings, Inc. News, Ratings, and Charts

UPST – The tech rally has been slowing over the past few months as investors focus on cyclical and outdoor stocks amid the fast-paced macroeconomic recovery. This, coupled with production bottlenecks and concerns surrounding cybercrime, has made Wall Street analysts bearish about fundamentally weak tech stocks Upstart Holdings (UPST) and Doximity, Inc. (DOCS). So, let’s discuss these names.

The technology industry has been front and center since last year as the dependence on technology accelerated because of the pandemic. 

However, this pandemic-driven tech boom might finally come to an end soon because the industry is facing several headwinds, ranging from a global semiconductor shortage to reduced e-commerce sales with the resurgence of brick-and-mortar shopping. In addition, concerns surrounding rising cybercrime constitute a significant challenge.

Because investors are expected to focus on cyclical and outdoor stocks amid the accelerated economic recovery, Wall Street analysts expect the prices of tech stocks Upstart Holdings, Inc. (UPST) and Doximity, Inc. (DOCS) to slump in the coming months.

Upstart Holdings, Inc. (UPST)

UPST is a cloud-based Artificial Intelligence (AI) platform that connects individuals, banks, and institutional investors that are striving to increase their access to credit and to reduce risk and cost. The company went public through the traditional IPO process on December 16, 2020, listing nine million shares on the Nasdaq stock exchange. UPST is headquartered in San Mateo, Calif.

On September 8, UPST announced a partnership with Water and Power Community Credit Union (WPCCU) to reach out to new customers and provide personal loans. However, this venture’s success depends on customers’ willingness and ability to borrow. Thus, it might take some time for UPST to profit from this partnership.

A few days earlier, UPST launched the Spanish language version of its personal-loans platform to  accelerate inclusivity. But the Spanish version of the auto loan product is still a ways off. In its  fiscal second quarter, ended June 30, UPST’s revenue increased 1,017.7% year-over-year to $193.95 million. However, its total operating expenses also increased 448.5% from the same period last year to $157.65 million. This can be attributed to a 1,296.5% year-over-year rise in sales and marketing expenses to $75.92 million.

The stock has gained 69.3% in price over the past three months and 107.6% over the past month. However, the $207.00, 12-month median price target for UPST indicates a 24.5% potential downside.

UPST’s POWR Ratings are consistent with this bleak outlook. The stock has an F  Stability grade, and a D Value grade. In the 106-stock, D-rated  Financial Services (Enterprise) industry, it is ranked #49. The POWR Ratings are calculated by considering 118 different factors, with each factor weighted to an optimal degree.

Click here to see additional POWR Ratings for UPST (Growth, Momentum, Sentiment, and Quality).

Click here to check out our Cloud Computing Industry Report for 2021

Doximity, Inc. (DOCS)

DOCS in San Francisco is  a cloud-based digital platform that provides tools, news and research for medical professionals. The company went public with an IPO listing of its class A common stock on June 24, 2021.

On April 20, before the company went public, it declared that 150 health systems had subscribed to its Doximity Dialer Enterprise to  supply telehealth services directly to patients at a distance. However, as people reschedule in-person health check-ups with the gradual economic reopening, the services’ subscription rate might decelerate in the coming months.

Although DOCS’ revenue increased 99.7% year-over-year to $72.7 million in its  first fiscal quarter of 2022, ended June 30, its non-GAAP operating expense also rose 37.6% from the same period last year to $34.68 million. Its non-GAAP sales and marketing expenses increased 42% from the prior-year quarter to $18.08 million.

The stock was down 4.6% in price over the past five days to close yesterday’s trading session at $93.75. Analysts expect the stock to hit $63.50 soon, indicating a 32.3% potential downside.

Under POWR Ratings, DOCS has been accorded a D rating for Value and Stability. Additionally, it is ranked #40 of 82 in the Medical – Services industry.

To see additional POWR Ratings for Growth, Momentum, Sentiment, and Quality for DOCS, click here.

Click here to checkout our Healthcare Sector Report for 2021


UPST shares were trading at $287.76 per share on Thursday afternoon, up $13.43 (+4.90%). Year-to-date, UPST has gained 606.16%, versus a 20.95% rise in the benchmark S&P 500 index during the same period.


About the Author: Anushka Dutta


Anushka is an analyst whose interest in understanding the impact of broader economic changes on financial markets motivated her to pursue a career in investment research. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
UPSTGet RatingGet RatingGet Rating
DOCSGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

2 Best Stocks of All Time!

This bear market has me thinking back to my 2 best trades of all time. That being when I bought Amazon (AMZN) and Booking (BKNG) back in 2001 as they were tumbling down in the midst of a bear market...but now enjoying truly phenomenal gains. Let’s discuss what those investments had in common and how that will help us find more big winners in the years ahead. Read on below for more...

:  |  News, Ratings, and Charts

Bears Back in Charge...What Happens Next?

A month ago the bulls were claiming victory as they created a charge back over 4,000 for the S&P 500 (SPY). Since then that false narrative has been peeled away and investors are more honestly looking at the bleak outlook formed by high inflation and a hawkish Fed. That explains why we are back retesting the June lows. Now we have to ponder what comes next and how to trade our way to profits. Read on below for the full story...

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

:  |  News, Ratings, and Charts

Cut These 2 Stocks From Your Portfolio Right Now

The Fed succeeding in a ‘soft landing’ seems unlikely. Analysts are expecting a recession soon. So, with the rising odds of the Fed raising rates aggressively, it could be wise to steer clear of fundamentally weak stocks Roblox (RBLX) and Affirm Holdings (AFRM). Read on…

:  |  News, Ratings, and Charts

3 Healthcare Stocks Under $100 to Buy Right Now

The rising prevalence of chronic diseases and the aging population are major growth drivers for the healthcare industry. In addition, increased investments in technological advancements should further bolster the industry’s growth. Thus, we think it may be prudent to buy quality healthcare stocks Pfizer Inc. (PFE), Merck & Co. (MRK), and Bristol-Myers Squibb (BMY), which are currently trading under $100. Read on…

Read More Stories

More Upstart Holdings, Inc. (UPST) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All UPST News